Description
A nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. May be a modulator of the AMPA receptor. Limited recreational value.
Effects & Dosing
Dosage
Oral
| Light | Common | Strong |
|---|---|---|
| 3-5 mg | 5-10 mg | 10-20 mg+ |
Duration
Oral
Onset 15 min - 30 min
Total Duration 3h - 6h
After Effects 1h - 4h
Everything in OpenMind
Track your use, check combinations and find safer use tips – even offline.